Innovation in cardiovascular disease diagnosis
Cardiovascular diseases account for 1.9 million deaths each year in the EU, posing one of the most frequent causes of death. The EU-funded Wirecath project aims to fund, clinically validate and provide an innovative medical device for diagnosing myocardial disease and narrowing in the coronary arteries. This technology offers high accuracy, improved cost-efficiency and greater manoeuvrability. It is founded on a sturdy non-complex base that uses novel positioning of pressure sensors that reduce the risk of hydrostatic errors that would usually lead to a diagnosis that misjudges the intensity of the disease.
Fields of science
Call for proposalSee other projects for this call
Funding SchemeSME-1 - SME instrument phase 1
753 23 Uppsala
See on map